News Center
Home/News
News Center / Company news
Congratulations to Lunarsun on the Successful Approval of Famotidine Injection!
2024.08.05

Beijing Lunarsun Pharma is pleased to share that the Famotidine Injection was approved for production on on August 5, 2024

Approval Number: H20244490

We welcome inquiries from pharmaceutical companies interested in collaboration.

Prev：Congratulations to Lunarsun on the Successful Status Upgrade of Mirabegron to “Active”!
Return
More
Our new website has launched on December 26, 2024.
2024.12.26
Congratulations to Lunarsun on the Successful Approval of Tigecycline for Injection!
2024.09.14
Congratulations to Lunarsun on the Successful Approval of Famotidine Injection!
2024.08.05

Copyright(C)2024,Beijing Lunarsun Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice